tiprankstipranks
Advertisement
Advertisement

AU:LTP Stock Latest News

LTR Pharma outlines limits and legal caveats in latest investor update
Company AnnouncementsLTR Pharma outlines limits and legal caveats in latest investor update
12d ago
LTP
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
PremiumCompany Announcements
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
14d ago
LTP
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
PremiumCompany Announcements
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
15d ago
LTP
LTR Pharma issues cautionary investor update on non-offer presentation
PremiumCompany Announcements
LTR Pharma issues cautionary investor update on non-offer presentation
2M ago
LTP
LTR Pharma completes recruitment for key Phase II SPONTAN study
PremiumCompany Announcements
LTR Pharma completes recruitment for key Phase II SPONTAN study
2M ago
LTP
LTR Pharma lodges half-year Appendix 4D report with ASX
PremiumCompany AnnouncementsLTR Pharma lodges half-year Appendix 4D report with ASX
3M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
Premium
Company Announcements
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
3M ago
LTP
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
Premium
Company Announcements
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
3M ago
LTP
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany Announcements
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
4M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
PremiumCompany Announcements
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
4M ago
LTP
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
PremiumCompany Announcements
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
4M ago
LTP
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany Announcements
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
4M ago
LTP
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
PremiumCompany AnnouncementsLTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
4M ago
LTP
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
Premium
Company Announcements
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
5M ago
LTP
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
Premium
Company Announcements
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
5M ago
LTP
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
PremiumCompany Announcements
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
5M ago
LTP
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
PremiumCompany Announcements
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
5M ago
LTP
LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
PremiumCompany Announcements
LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
5M ago
LTP
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
PremiumCompany Announcements
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
6M ago
LTP
LTR Pharma Limited Announces Change in Director’s Interest
PremiumCompany AnnouncementsLTR Pharma Limited Announces Change in Director’s Interest
6M ago
LTP
LTR Pharma Announces Director’s Interest Change
Premium
Company Announcements
LTR Pharma Announces Director’s Interest Change
6M ago
LTP
LTR Pharma Issues Unquoted Equity Securities for Employee Incentive
Premium
Company Announcements
LTR Pharma Issues Unquoted Equity Securities for Employee Incentive
6M ago
LTP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >